Jefferies LLC

Georgia Healthcare Group launched on Monday its initial public offering on London’s main market, as it aims to follow in the footsteps of its sole owner, Bank of Georgia, which is already listed there.

Quick Heal Technologies, which makes anti-virus software, has lodged a draft prospectus with the Securities and Exchange Board of India for an IPO that could raise $100m-$150m.

Regulation of leveraged finance in the US remains one of the main topics of conversation, as well as a mixed blessing, for the European market, delegates at the 9th annual Leveraged Finance Conference in London were told on Monday.

Symetis, the Swiss heart valves maker, cancelled its planned initial public offering in Zurich on Tuesday, blaming “adverse market conditions” for the decision.

Sandhar Technologies has filed a listing application with the Securities and Exchange Board of India, with ICICI Securities, IDFC Securities, IIFL Holdings and Jefferies leading the trade.

Symetis, the Swiss company that makes heart valves, began the bookbuild for its Sfr80m IPO on the SIX Swiss Exchange on Tuesday.

Symetis, a Swiss company that makes artificial heart valves, began investor education on Tuesday for an IPO of up to Sfr80m on SIX Swiss Exchange.

Apax is acquiring a majority stake in FullBeauty Brands, the US plus-size fashion retailer, and has obtained the commitment of four banks to the deal’s debt financing.

Jefferies has boosted its high yield trading business in London with the hire of a senior trader from Societe Generale.

Amdipharm Mercury, the UK generic pharmaceuticals company also known as AMCo, has allocated a €603.2m loan that raises new money and reprices existing facilities.

Amdipharm Mercury, the UK generic pharmaceuticals company also known as AMCo, has allocated a €603.2m loan that raises new money and reprices existing facilities.